Sierra Oncology, Inc: Q4 Earnings Snapshot
SAN MATEO, Calif. (AP) _ Sierra Oncology, Inc (SRRA) on Thursday reported a loss of $25.5 million in its fourth quarter.
On a per-share basis, the San Mateo, California-based company said it had a loss of $1.67.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.60 per share.
For the year, the company reported a loss of $94.7 million, or $7.14 per share.